Advertisement
Document › Details
Eaton, Elizabeth S. [BioCentury]. (3/22/19). "News: Hookipa Proposes IPO as Its Cancer Vaccines Head towards the Clinic".
Region | United States (USA) | |
Organisation | Hookipa Pharma Inc. (Nasdaq: HOOK) | |
Group | Hookipa (Group) | |
Organisation 2 | Nasdaq | |
Group | Nasdaq OMX (Group) | |
Product | HB-101 (Hookipa) | |
Product 2 | HB-201 (Hookipa) | |
Index term | Hookipa–SEVERAL: investment, 201903–201904 IPO $84m+$12.6m with 6m+900k shares common stock at Nasdaq Global Select Market | |
Original document
accessed by [iito] on 2019-03-23
Record changed: 2023-06-05 |
Advertisement
More documents for Hookipa (Group)
- [1] Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna....
- [2] Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna....
- [3] Hookipa Pharma Inc.. (5/31/23). "Press Release: Hookipa Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock". New York, NY & Vienna....
- [4] Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna....
- [5] Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna....
- [6] Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna....
- [7] Hookipa Pharma Inc.. (10/6/21). "Press Release: Groundbreaking Ceremony for Hookpia’s New Production Site". Vienna....
- [8] Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan....
- [9] Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna....
- [10] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top